SG/CALL/DERMAPHARM HOLDING/42/0.1/20.06.25 Share Price

Warrant

DE000SW994X9

Real-time Boerse Frankfurt Warrants 14:39:15 08/07/2024 BST
0.35 EUR -5.41% Intraday chart for SG/CALL/DERMAPHARM HOLDING/42/0.1/20.06.25
Current month+15.62%
1 month-2.63%
Date Price Change
08/07/24 0.35 -5.41%
05/07/24 0.37 +8.82%
04/07/24 0.34 +6.25%
03/07/24 0.32 0.00%
02/07/24 0.32 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 02:39 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SW994X
ISINDE000SW994X9
Date issued 13/05/2024
Strike 42
Maturity 20/06/2025 (347 Days)
Parity 10 : 1
Emission price 0.28
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.4
Lowest since issue 0.25
Delta0.46x
Omega 4.588
Premium23.85x
Gearing9.97x
Moneyness 0.8786
Difference Strike 5.525
Difference Strike %+13.15%
Spread 0.02
Spread %5.26%
Theoretical value 0.3600
Implied Volatility 34.80 %
Total Loss Probability 67.24 %
Intrinsic value 0.000000
Present value 0.3600
Break even 45.60 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.1 EUR
Average target price
50.12 EUR
Spread / Average Target
+35.11%
Consensus